319460-94-1
319460-94-1
Chemical Structure
AG-13958
Synonym(s): AG-013958
- CAS. Nr.: 319460-94-1
- Formula:C26H22FN7O
- Molecular Weight:467.50
IUPAC Name: (E)-N-(2-fluoro-5-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)amino)phenyl)-1,3-dimethyl-1H-pyrazole-5-carboxamide
InChIKey: JXSVVZKPEDIRTN-DHZHZOJOSA-N
SMILES: O=C(C1=CC(C)=NN1C)NC2=CC(NC3=CC4=C(C=C3)C(/C=C/C5=NC=CC=C5)=NN4)=CC=C2F
Biological Activity: AG-13958 (AG-013958), a potent VEGFR tyrosine kinase inhibitor, is used for treatment of choroidal neovascularization associated with age-related macular degeneration (AMD)[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AG-13958 | 99.69% | AG-13958 (AG-013958), a potent VEGFR tyrosine kinase inhibitor, is used for treatment of choroidal neovascularization associated with age-related macular degeneration (AMD). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
